Emmanuelle Charpentier directs this Berlin institute, which studies how disease-causing bacteria work. It is a reminder of where CRISPR came from: not from anyone trying to invent a gene-editing tool, but from basic curiosity about bacterial biology.
Go deeper
The Max Planck Unit for the Science of Pathogens in Berlin, founded in 2018, is directed by Emmanuelle Charpentier and studies the molecular biology of human bacterial pathogens, including the regulatory RNA biology from which CRISPR-Cas9's mechanism was elucidated.
Educational information only
This page is a reference, not medical advice. Research and regulatory status change; check the last-updated date above and confirm anything important against the primary sources listed.
You are leaving CRISPR Decoded
This link opens a website we do not run. We cannot control its content, its accuracy, or how it handles your data, including its own cookies and tracking. Nothing you read there has been reviewed by us.
